{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:43:21Z","timestamp":1788871401121,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Centers at Minority Institutions (RCMI)","award":["G12 RR 03020"],"award-info":[{"award-number":["G12 RR 03020"]}]},{"name":"Title III"},{"name":"Pharmaceutical Research Center","award":["NIH\/NCRR 1C06-RR12512-01"],"award-info":[{"award-number":["NIH\/NCRR 1C06-RR12512-01"]}]},{"name":"Division of AIDS","award":["AI 27094"],"award-info":[{"award-number":["AI 27094"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejmech.2013.09.044","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T08:02:22Z","timestamp":1380960142000},"page":"130-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Structure\u2013activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents"],"prefix":"10.1016","volume":"70","author":[{"suffix":"Jr.","given":"Sidney","family":"Bolden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Y.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagan R.","family":"Etukala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Comfort","family":"Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tryphon","family":"Mazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan","family":"Flores-Rozas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabana I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth Y.","family":"Ablordeppey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.09.044_bib1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.amjmed.2007.04.001","article-title":"Antimicrobial resistance prevention initiative\u2013an update: proceedings of an expert panel on resistance","volume":"120","author":"Moellering","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2013.09.044_bib2","doi-asserted-by":"crossref","first-page":"e1002870","DOI":"10.1371\/journal.ppat.1002870","article-title":"Antifungal drug discovery: something old and something new","volume":"8","author":"Butts","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2013.09.044_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"Aids"},{"key":"10.1016\/j.ejmech.2013.09.044_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10156-007-0595-7","article-title":"Current challenges in the\u00a0management of invasive fungal infections","volume":"14","author":"Lai","year":"2008","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.ejmech.2013.09.044_bib5","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.1989.00390100145030","article-title":"Risk factors for hospital-acquired candidemia. A matched case-control study","volume":"149","author":"Wey","year":"1989","journal-title":"Arch. Intern. Med."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ejmech.2013.09.044_bib6","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki218","article-title":"Changing patterns and trends in systemic fungal infections","volume":"56","author":"Richardson","year":"2005","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2013.09.044_bib7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A\u00a0randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.09.044_bib8","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","volume":"39","author":"Pfaller","year":"2001","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2013.09.044_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/01.CCM.0000201897.78123.44","article-title":"Invasive candidiasis in the intensive care unit","volume":"34","author":"Ostrosky-Zeichner","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejmech.2013.09.044_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2013.09.044_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2013.09.044_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00001432-200212000-00003","article-title":"Recent trends in the epidemiology of invasive mycoses","volume":"15","author":"Clark","year":"2002","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2013.09.044_bib13","doi-asserted-by":"crossref","first-page":"e46133","DOI":"10.1371\/journal.pone.0046133","article-title":"Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients","volume":"7","author":"Tobudic","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2013.09.044_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2013.09.044_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1471-4914(02)02280-3","article-title":"Molecular basis of resistance to azole antifungals","volume":"8","author":"Lupetti","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2013.09.044_bib16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2013.09.044_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0968-0896(98)00244-2","article-title":"Probing the N-5 region of the indoloquinoline alkaloid, cryptolepine for anticryptococcal activity","volume":"7","author":"Ablordeppey","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.044_bib18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bmc.2006.10.062","article-title":"Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents","volume":"15","author":"Zhu","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.044_bib19","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.ejmech.2011.03.021","article-title":"delta-Carbolines and their ring-opened analogs: synthesis and evaluation against fungal and bacterial opportunistic pathogens","volume":"46","author":"Mazu","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.044_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2013.08.043","article-title":"CoMFA studies and in\u00a0vitro evaluation of some 3-substituted benzylthio quinolinium salts as anticryptococcal agents","author":"Bolden","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.044_bib21","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1158\/0008-5472.CAN-07-2399","article-title":"Identification of genes required for protection from doxorubicin by a genome-wide screen in Saccharomyces cerevisiae","volume":"67","author":"Xia","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2013.09.044_bib22","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1158\/0008-5472.CAN-04-4093","article-title":"Genome-wide screen identifies genes whose inactivation confer resistance to cisplatin in Saccharomyces cerevisiae","volume":"65","author":"Huang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2013.09.044_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0960-9822(99)80047-5","article-title":"Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes","volume":"9","author":"Durant","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2013.09.044_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tips.2005.03.004","article-title":"Yeast as a model for medical and medicinal research","volume":"26","author":"Mager","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2013.09.044_bib25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bmc.2010.11.008","article-title":"Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: synthesis and evaluation against opportunistic fungal pathogens","volume":"19","author":"Boateng","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.044_bib26","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.ejmech.2011.02.034","article-title":"Optimization of 3-(phenylthio)quinolinium compounds against opportunistic fungal pathogens","volume":"46","author":"Boateng","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.044_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/ol0171867","article-title":"Copper-catalyzed coupling of alkylamines and aryl iodides: an efficient system even in an air atmosphere","volume":"4","author":"Kwong","year":"2002","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2013.09.044_bib28","doi-asserted-by":"crossref","first-page":"14844","DOI":"10.1021\/ja028865v","article-title":"Copper-catalyzed halogen exchange in aryl halides: an aromatic Finkelstein reaction","volume":"124","author":"Klapars","year":"2002","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.09.044_bib29","doi-asserted-by":"crossref","DOI":"10.1021\/jo01351a093","article-title":"Notes-N-methylpyrrolidone as solvent for reaction of aryl halides with cuprous cyanide","volume":"26","author":"Newman","year":"1961","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2013.09.044_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/cmi.12091","article-title":"Two unlike cousins: Candida albicans and C.\u00a0glabrata infection strategies","volume":"15","author":"Brunke","year":"2013","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejmech.2013.09.044_bib31","doi-asserted-by":"crossref","first-page":"2005.0001","DOI":"10.1038\/msb4100004","article-title":"A\u00a0global view of pleiotropy and phenotypically derived gene function in yeast","volume":"1","author":"Dudley","year":"2005","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejmech.2013.09.044_bib32","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/EC.00266-07","article-title":"A\u00a0chemogenomic screening of sulfanilamide-hypersensitive Saccharomyces cerevisiae mutants uncovers ABZ2, the gene encoding a fungal aminodeoxychorismate lyase","volume":"6","author":"Botet","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ejmech.2013.09.044_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tox.2004.11.026","article-title":"In\u00a0vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine","volume":"208","author":"Ansah","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2013.09.044_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)81846-2","article-title":"A\u00a0novel mutation avoidance mechanism dependent on S.\u00a0cerevisiae RAD27 is distinct from DNA mismatch repair","volume":"88","author":"Tishkoff","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2013.09.044_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/genetics\/137.1.19","article-title":"Interaction between mismatch repair and genetic recombination in Saccharomyces cerevisiae","volume":"137","author":"Alani","year":"1994","journal-title":"Genetics"},{"key":"10.1016\/j.ejmech.2013.09.044_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11745-006-1397-x","article-title":"Synthesis and in\u00a0vitro cytotoxic activity of N-, F-, and S-ether derivatives of podophyllotoxin fatty acid adducts","volume":"40","author":"Mustafa","year":"2005","journal-title":"Lipids"},{"key":"10.1016\/j.ejmech.2013.09.044_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11745-005-1386-0","article-title":"Anticancer activity and possible mode of action of 4-O-podophyllotoxinyl 12-hydroxyl-octadec-Z-9-enoate","volume":"40","author":"Ma","year":"2005","journal-title":"Lipids"},{"key":"10.1016\/j.ejmech.2013.09.044_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2253-9-2","article-title":"Efficacy of sub-Tenon's block using an equal volume of local anaesthetic administered either as a single or as divided doses. A randomised clinical trial","volume":"9","author":"Khan","year":"2009","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.ejmech.2013.09.044_bib39","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","article-title":"Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium","volume":"41","author":"Collins","year":"1997","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413006259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413006259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T18:10:16Z","timestamp":1646676616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413006259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":39,"alternative-id":["S0223523413006259"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.044","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure\u2013activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}